Vaxneuvance, Prevnar 20 Earn CDC Cmte Nod For Age- And Risk-Based Use; Broader Shingrix Use Supported

ACIP votes unanimously to recommend Merck and Pfizer’s pneumococcal vaccines in elderly and immunocompromised adults; GSK’s herpes zoster vaccine also gets unanimous nod for immunocompromised adults.

Lonely White Sailboat (Alamy)
VACCINES FROM PFIZER, MERCK AND GSK SAILED THROUGH THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES. • Source: Alamy

New pneumococcal conjugate vaccines from Pfizer Inc. and Merck & Co., Inc. and use of GlaxoSmithKline plc’s herpes zoster vaccine Shingrix in immunocompromised adults sailed through the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices on 20 October, resulting in three unanimous votes to recommend use of vaccines.

ACIP has been holding to a swift pace of non-COVID-19 vaccine assessments despite the tremendously increased workload before the committee...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet